Skip to content

The University of Kansas Health System, University of Kansas Medical Center, Children’s Mercy, and BAMF Health to Develop Fully Integrated Destination Theranostic Research and Treatment Center

The University of Kansas Health System, the University of Kansas Medical Center, Children’s Mercy and BAMF Health announced intentions to establish one of the nation’s first fully integrated Theranostics platforms for both adult and pediatric patients.

Read more

February 17, 2026

It Takes Courage. God Gave Me Courage.

With a zest and appreciation for life, at 77 years old, Barbara considered herself the picture of perfect health. But that changed in June of 2025 when she was diagnosed with metastatic HR-/HER2+ breast cancer.

Read more

October 2, 2025

East River Medical Imaging Selected as First BAMF RadioNexus Site in the New York City Area

Partnership brings new cancer trial and treatments to patients in New York City and Westchester.

Read more

September 9, 2025

What We’re Learning about Pre-Chemotherapy Treatment with Pluvicto®

We’re among the first centers in the country to treat patients in the new “pre-chemo” setting. Here’s what we’re learning—and what we’re still working to understand.

Read more

September 2, 2025

Join the BAMF Health 108 Walk for Prostate Cancer

Join us this September as we raise awareness for prostate cancer by walking 108 miles!

Read more

August 18, 2025

BAMF Health, Ferris State, KentISD expand partnership to accelerate high schoolers’ path toward innovative STEM careers

Enrollment for this year’s FutureSolve program is nearly double last year’s.

Read more

July 6, 2025

BAMF Health Launches National Clinical Trials Platform, BAMF RadioNexus, and Enrolls National Health System

RadioNexus is the world’s first radiopharmaceutical-focused clinical trials network.

Read more

June 18, 2025

Prostate Cancer Patients Now Have an Option Other Than Chemotherapy

Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.

Read more

May 12, 2025

BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis

BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.

Read more

April 28, 2025

BAMF Health seeks breast cancer patients for groundbreaking imaging study

This non-invasive clinical trial aimed to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.

Read more

April 24, 2025